![Dhaval Desai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dhaval Desai
Corporate Officer/Principal at
4D MOLECULAR THERAPEUTICS, INC.
Profile
Dhaval Desai is Chief Development Officer at 4D Molecular Therapeutics, Inc. since 2024.
Former positions include Global Director-Medical Affairs at Thrombogenics, Inc. from 2011 to 2014; Vice President-Medical Affairs at Aerpio Therapeutics LLC; Vice President & Head-US Ophthalmics at Novartis AG from 2018 to 2020; Chief Strategy Officer & VP-Medical Affairs at Aerpio Pharmaceuticals, Inc. from 2014 to 2018; and Chief of Staff at IVERIC bio, Inc. from 2020 to 2021.
Education includes a doctorate from Rutgers State University of New Jersey.
Dhaval Desai active positions
| Companies | Position | Start |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Corporate Officer/Principal | 2024-09-24 |
Former positions of Dhaval Desai
| Companies | Position | End |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 2020-07-31 |
| AERPIO PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | - |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Corporate Officer/Principal | 2014-06-30 |
| IVERIC BIO, INC. | Human Resources Officer | 2021-03-31 |
Aerpio Therapeutics LLC
 Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Chief Tech/Sci/R&D Officer | - |
Training of Dhaval Desai
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Aerpio Therapeutics LLC
Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Dhaval Desai
